Search Results 391-400 of 36425 for Ovary

1. Metabolite Levels In Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors - Mayo Clinic

   The purpose of this study is to determine the extent to which PARP inhibitor (PARPi) treatment reduces systemic levels of mesenchymal stem cell (MSC)-derived ...

2. Avatar-Directed Chemotherapy In Treating Patients With Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer - Mayo Clinic

   This phase II trial studies how well Avatar-directed chemotherapy works in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that ...

3. A Study for Women who have Platinum Resistant Ovarian Cancer to Evaluate EC145 Combined with Pegylated Liposomal Doxorubicin, Compared to Pegylated Liposomal Doxorubicin Alone - Mayo Clinic

   The purpose of this study is to compare the progression-free survival in women who have platinum-resistant ovarian cancer, who receive combination therapy ...

4. Olaparib Monotherapy In Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. - Mayo Clinic

   About this study. Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy. Participation eligibility.

5. Genetic Testing Generates Optimism for Ovarian Cancer Treatment - Mayo Clinic News Network

   When Jean Niven learned she had ovarian cancer, her desire to find a knowledgeable, compassionate physician led her to Mayo Clinic. Then, when her cancer ...

6. A Study to Measure Anti-Mullerian Hormone for the Prediction of Response to Ovarian Stimulation - Mayo Clinic

   The purpose of this study is to identify the measurement of anti-mullerian hormone present that can specifically identify a 90% prediction of a poor ovarian ...

7. A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation - Mayo Clinic

   The study population is adult patients with asymptomatic recurrent ovarian cancer who have an elevation in their CA-125 level. Participation eligibility.

8. Novel Gene Drives Development of Different Types of Ovarian Cancer, Mayo Led Study Finds

   Ovarian cancer is the most common cause of death from gynecological cancers in the U.S.. In their study, Dr. Goode and her collaborators showed that variations ...

9. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

   The purpose of this Phase 1a/1b study of SC-003 in patients with platinum-resistant/refractory ovarian cancer is to characterize the safety and tolerability ...

10. A Study to Investigate the Safety and Effectiveness of FE 999049 in Controlled Ovarian Stimulation in Women Aged 35-42 Years Old - Mayo Clinic

    A Study to Investigate the Safety and Effectiveness of FE 999049 in Controlled Ovarian Stimulation in Women Aged 35-42 Years Old ... Known tumors of the ovary, ...